Most febrile seizures are harmless, and fever medicine will not prevent them
US and UK guidelines converge: a brief seizure during a fever in a young child rarely needs scans or blood tests, and paracetamol and ibuprofen do not stop them recurring.
A febrile seizure — a convulsion triggered by a fever in a young child — is frightening to witness but, in its common form, medically benign, and no fever medicine has been shown to prevent one. The American Academy of Pediatrics and the UK's National Institute for Health and Care Excellence agree on two points parents rarely hear clearly: a simple febrile seizure usually does not require brain scans, blood tests, or an EEG, and paracetamol and ibuprofen do not stop these seizures from happening or recurring [s1] [s2] [s3].
None of that makes a seizure something to handle alone. The guidance below describes what the evidence and the guidelines say; a seizure in a child is a reason to seek medical attention, and this article is not a substitute for that.
What a febrile seizure is
Febrile seizures are the most common seizure disorder of childhood, affecting 2% to 5% of children between the ages of 6 and 60 months [s1]. The AAP defines a simple febrile seizure precisely: a brief seizure, lasting less than 15 minutes, that is generalised (involving the whole body rather than one part), occurs only once in a 24-hour period, and happens in a febrile child who does not have an intracranial infection, a metabolic disturbance, or a history of seizures without fever [s1]. Seizures that are longer, focal, or recur within a day fall outside this definition and are assessed differently.
The distinction is the whole point of the guidelines. A simple febrile seizure and a first seizure that might signal something more serious can look similar in the moment, which is why evaluation focuses on separating them.
Why most do not need scans or blood tests
The AAP's neurodiagnostic guideline is unusually direct about how little routine testing a simple febrile seizure warrants. After such a seizure in a child aged 6 to 60 months, it advises that "a simple febrile seizure does not usually require further evaluation, specifically electroencephalography, blood studies, or neuroimaging" [s2]. Instead, the guideline directs clinicians' attention to identifying the cause of the child's fever — the ordinary infection behind it — rather than to imaging the brain [s2].
The one thing the guideline does keep firmly in view is meningitis. It states that meningitis should be considered in the differential diagnosis for any febrile child, and that a lumbar puncture should be performed if there are clinical signs or symptoms of concern [s2]. For infants between 6 and 12 months, a lumbar puncture is described as an option when the child has not received the scheduled Haemophilus influenzae type b or pneumococcal immunisations, or when immunisation status is unknown, because of the higher risk of bacterial meningitis in that group [s2]. In other words, the evaluation is aimed at ruling out serious infection, not at investigating the seizure itself.
Why fever medicine does not prevent them
A natural instinct is to treat every fever aggressively to head off a seizure. The evidence does not support that this works. NICE states plainly that "antipyretic agents do not prevent febrile convulsions and should not be used specifically for this purpose" [s3]. NICE separately advises against using paracetamol or ibuprofen with the sole aim of reducing a child's temperature, reserving them for a child who appears distressed [s3].
The AAP's long-term management guideline reached the question from the other side, weighing whether any preventive treatment is justified. It examined the risks and benefits of both continuous and intermittent anticonvulsant therapy, as well as antipyretics, in children with simple febrile seizures [s1]. The framework it lays out is one of weighing modest or unproven benefit against the real downsides of medicating an otherwise healthy child — the reason routine preventive drug treatment is not the default [s1].
What the guidelines leave to a clinician
What the evidence settles is the general shape: simple febrile seizures are common, usually benign, rarely need extensive testing, and are not prevented by fever medicine [s1] [s2] [s3]. What it does not do is let a parent classify a seizure at home. Whether a given seizure was simple or complex, whether meningitis needs to be excluded, and whether a particular child warrants further evaluation are clinical judgments that depend on the child's age, immunisation status, examination, and the features of the seizure itself — exactly the variables the AAP guidelines route to a clinician [s2].
This article is informational and is not medical advice. A seizure in a child, a first seizure, a seizure lasting more than a few minutes, or a feverish child who is difficult to rouse or has a stiff neck are reasons to seek emergency medical care rather than to manage the situation at home.
Sources
- Febrile Seizures: Clinical Practice Guideline for the Long-term Management of the Child With Simple Febrile Seizures — Pediatrics (American Academy of Pediatrics) , June 1, 2008
- Neurodiagnostic Evaluation of the Child With a Simple Febrile Seizure — Pediatrics (American Academy of Pediatrics) , February 1, 2011
- Fever in under 5s: assessment and initial management (NG143), Recommendations — National Institute for Health and Care Excellence , November 26, 2021
More on
NICE tells clinicians not to treat a child's fever just to bring the number down
Its guideline says antipyretics should be considered when a feverish child appears distressed, not to lower a temperature. In critically ill adults, paracetamol for fever changed nothing.
Teething does not cause fever, and blaming it can mask real illness
A meta-analysis of 16 studies and a daily-temperature cohort agree: tooth eruption brings gum irritation, drooling and fussiness, and at most a slight temperature rise — not a true fever.
NSAIDs raise kidney-injury risk modestly — but sharply in a few specific situations
Across studies, current NSAID use was tied to about a 73% higher odds of acute kidney injury, more in older people and those with existing kidney disease. The combination with two blood-pressure drugs is the real hazard.
Paracetamol did not beat placebo in the trial built to test it for back pain
PACE randomised patients across 235 primary care centres and found recovery took 17 days on the drug and 16 days on placebo. For osteoarthritis the picture differs, but not flatteringly.